Novavax, Inc. (NVAX)

NASDAQ: NVAX · USD

$10.3

+0.29 (+2.9%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	413.8M
Net income (ttm)	-247.7M
EPS (ttm)	-$1.52
Shares out	164.9M
Volume	4,004,736
Beta	2.43

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 413.8M
Net income (ttm): -247.7M
EPS (ttm): -$1.52
Market cap: 1.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-18

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NVAX indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001000694
Company name	Novavax, Inc.
Country	United States
Country code	US
CUSIP number	670002401
Earnings date	2026-11-09
Earnings time	bmo
Employees	749
Employees change	-203
Employees growth	-21.32%
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1987
In index	RUSSELL2000
Industry	Biotechnology
IPO date	1995-12-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US6700024010
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2019-05-10
Last stock split type	Reverse
Market cap	$1.7B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$10.32
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	NVAX
U.S. state	Maryland
Website	https://www.novavax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.72%
EV/Sales	3.05x
FCF / EV yield	-3.34%
FCF yield	-2.5%
Forward EV/Sales	6.23x
Forward P/S	8.31x
P/S ratio	4.07x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-28.85%
EBITDA margin	-24.54%
Gross margin	-2.56%
Operating margin	-28.85%
Pretax margin	-59.28%
Profit margin	-59.87%
Profit per employee	$-330,748
Profitable years	1
Revenue per employee	$552,465
ROA	-6.51%
ROA (5Y)	-13.46%
ROCE	-19.1%
ROIC	-18.01%
SBC / revenue	7.81%
Tax / revenue	0.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	4
Net income growth years	4
Revenue growth	-61.64%
Revenue growth (Q)	-76.3%
Revenue growth (QoQ)	-59.36%
Revenue growth 10Y	36.01%
Revenue growth 3Y	-36.25%
Revenue growth 5Y	-18.93%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-5.3M
Depreciation and amortization	$17.8M
EBIT	$-119.4M
EBITDA	$-101.6M
EPS	$-1.52
FCF per share	$-0.26
Financing cash flow	$74.7M
Free cash flow	$-42.2M
Free cash flow minus SBC	$-74.5M
Gross profit	$-10.6M
Income taxes	$2.4M
Investing cash flow	$-109.5M
Net borrowing	$80.7M
Net cash flow	$-72.9M
Net income	$-247.7M
Operating cash flow minus SBC	$-69.2M
Operating income	$-119.4M
Revenue	$413.8M
Stock-based compensation	$32.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-5.5
Book value per share	$-1.16
Goodwill	$112.5M
Interest coverage	-5.2
Long-term assets	$184.5M
Long-term liabilities	$815.7M
Net cash (debt)	$422M
Net cash / market cap	25.03%
Net cash growth	9.95%
Piotroski F-Score	1
Property, plant and equipment	$58M
Shareholders' equity	$-190.7M
Tangible book value	$-303.2M
Tangible book value per share	$-1.84
Total assets	$955.6M
Total cash	$719.3M
Total debt	$297.3M
Total liabilities	$1.1B
WACC	15.91%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.36
Current assets	$771.1M
Current liabilities	$330.6M
Current ratio	2.33
Inventory turnover	41.92
Net working capital	$-274.7M
Quick ratio	2.23
Working capital	$440.5M
Working capital turnover	0.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.06%
Dividend yield	0%
Shareholder yield	3.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-65.84%
10Y return CAGR	-10.19%
10Y total return	-65.84%
150-day SMA	$9.25
15Y price change	-69.66%
15Y return CAGR	-7.64%
15Y total return	-69.66%
1D price change	2.94%
1M price change	-2.96%
1M total return	-2.96%
1W price change	-6.31%
1W total return	-6.31%
1Y price change	18.56%
1Y return CAGR	18.58%
1Y total return	18.56%
20-day SMA	$11.24
200-day SMA	$9.28
20Y price change	-87.51%
20Y return CAGR	-9.88%
20Y total return	-87.51%
3M price change	37.72%
3M total return	37.72%
3Y price change	62.44%
3Y return CAGR	17.55%
3Y total return	62.44%
50-day SMA	$10.39
50-day SMA vs 200-day SMA	50over200
52-week high	$13.39
52-week high date	2026-10-05
52-week low	$6.20
52-week low date	2025-11-20
5Y price change	-92.71%
5Y return CAGR	-40.78%
5Y total return	-92.71%
6M price change	27.82%
6M total return	27.82%
All-time high	$331.68
All-time high date	2021-02-09
All-time low	$3.53
All-time low date	2024-02-05
Average true range (ATR)	$0.92
Average volume	9.1M
Beta (1Y)	2.52
Beta (2Y)	1.68
Beta (5Y)	2.43
Change from 52-week high	-22.94%
Change from 52-week low	66.37%
Change from all-time high	-96.89%
Change from all-time low	192.04%
Change from open	5.36%
Day's gap	-2.3%
Dollar volume	$41.3M
High price	$10.34
Low price	$9.75
Monthly RSI	48.56
Open price	$9.79
Position in 52-week range	95.76%
Premarket change	-2.69%
Premarket close	$10.02
Premarket price	$9.75
Premarket volume	34K
Previous close	$10.02
Price vs 150-day SMA	11.5%
Price vs 20-day SMA	-8.23%
Price vs 200-day SMA	11.2%
Price vs 50-day SMA	-0.75%
Relative volume	0.44
RSI	46.54
Sharpe ratio	0.53
Sharpe ratio (3Y)	0.57
Sharpe ratio (5Y)	-0.07
Sortino ratio	0.99
Sortino ratio (3Y)	1.2
Sortino ratio (5Y)	-0.06
Volume	4M
Weekly RSI	53.44
YTD price change	53.5%
YTD total return	53.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	146.2M
Float percentage	88.64%
Shares change (QoQ)	0.79%
Shares change (YoY)	-3.06%
Shares held by insiders	0.79%
Shares held by institutions	58.9%
Shares outstanding	164.9M
Short % of float	31.49%
Short % of shares	27.92%
Short ratio	8.1 days

Deeper analysis on NVAX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NVAX report

Is a complete NVAX research report available?

No complete published report is available for Novavax, Inc. (NVAX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Novavax, Inc. (NVAX)

Price

Financial snapshot

Fair-value bridge

Latest news · NVAX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NVAX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NVAX

Frequently asked questions